A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease
Recruiting · NCT06826612 · Registry updated 2026-05-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Randomized Study of SPK-10001 Gene Therapy in Participants With Huntington's Disease | Cognition Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Disease Attributes, Dyskinesias, Huntington disease, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Rare Diseases, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, choreatic disease, cognitive disorder, dementia, hereditary disease, inherited neurodegenerative disorder, movement disorder, nervous system disorder, neurodegenerative disease, psychiatric disorder | Recruiting | Phase 1 / Phase 2 | 2026-05-05 | NCT06826612 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hoffmann-La Roche | 280 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Ohio State University | Columbus | United States | 19 |
| University of Cincinnati/Cincinnati Children's Hospital | Cincinnati | United States | 1 |
| University of Pennsylvania | Philadelphia | United States | 23 |
| University of Pittsburg | Pittsburgh | United States | 4 |